Compositions and methods for treating phenylketonuria
T Lahusen, CD Pauza - US Patent 11,820,999, 2023 - Google Patents
A lentiviral vector system for expressing a lentiviral particle is disclosed. The lentiviral vector
system includes a therapeutic vector. The therapeutic vector comprises a phenylalanine …
system includes a therapeutic vector. The therapeutic vector comprises a phenylalanine …
[HTML][HTML] HIV and Viral Co-infections
Viral coinfections are common findings in HIV infected patients, notably those who share a
common route of infection with HIV (da Silva Neto et al., 2020). Some of those coinfections …
common route of infection with HIV (da Silva Neto et al., 2020). Some of those coinfections …
[HTML][HTML] Protocolo Brasileño para Infecciones de Transmisión Sexual 2020: infección por virus linfotrópico de células T humanas (HTLV)
C Rosadas, C Brites, D Arakaki-Sánchez… - … e Serviços de Saúde, 2021 - SciELO Brasil
El artículo está relacionado con el capítulo sobre virus linfotrópico de células T humanas
(human T lymphotropic virus, HTLV) que conforma el Protocolo Clínico y Directrices …
(human T lymphotropic virus, HTLV) que conforma el Protocolo Clínico y Directrices …
Combination vectors and methods for treating cancer
T Lahusen, ML Liou, L Xiao, H Li… - US Patent 10,975,374, 2021 - Google Patents
8,124,752 B2 8,287,857 B2 8,993,532 B2 9,522,176 B2 9,834,790 B1 9,914,938 B2
10,023,880 B2 10,036,038 B2 10,036,040 B2 10,137,144 B2 10,208,295 B2 10,233,464 B2 …
10,023,880 B2 10,036,038 B2 10,036,040 B2 10,137,144 B2 10,208,295 B2 10,233,464 B2 …
[HTML][HTML] Evaluation of the Inflammatory Cytokines and IL-10 Network in Individuals Co-infected With Human T-Cell Lymphotropic Virus and Hepatitis C Virus (HTLV …
FM Pereira, PIP Ramos, M Lirio, A Merces Atta… - Frontiers in …, 2021 - frontiersin.org
Background Co-infection between the human T-cell lymphotropic virus (HTLV) and the
hepatitis C virus (HCV) can modify the natural history of HCV infection. The aim of this study …
hepatitis C virus (HCV) can modify the natural history of HCV infection. The aim of this study …
Methods and compositions for the activation of gamma-delta T-cells
Related US Application Data (63) Continuation of application No. 16/182,443, filed on Nov.
6, 2018, now Pat. No. 10.428. 350, which is a continuation of application No. 16/008991 …
6, 2018, now Pat. No. 10.428. 350, which is a continuation of application No. 16/008991 …
Viral vectors for treating Parkinson's disease
T Lahusen, CD Pauza - US Patent 11,583,562, 2023 - Google Patents
2019-09-09 Assigned to AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
reassignment AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. ASSIGNMENT …
reassignment AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. ASSIGNMENT …
Non-integrating viral delivery system and methods related thereto
CD Pauza, T Lahusen - US Patent 11,976,292, 2024 - Google Patents
A non-integrating viral delivery system is disclosed. The system includes a viral carrier,
wherein the viral carrier contains a defective integrase gene; a heterologous viral episomal …
wherein the viral carrier contains a defective integrase gene; a heterologous viral episomal …
Hiv pre-immunization and immunotherapy
US11911458B2 - HIV pre-immunization and immunotherapy - Google Patents
US11911458B2 - HIV pre-immunization and immunotherapy - Google Patents HIV pre-immunization …
US11911458B2 - HIV pre-immunization and immunotherapy - Google Patents HIV pre-immunization …